Latest Recurring Revenue News

Knosys reports steady revenue growth and a strategic partnership to upgrade its GreenOrbit platform, while accelerating development of its AI-powered Libero X library solution for a global launch next year.

Stakk Ltd aims to nearly double its annual recurring revenue to $15 million by mid-2026, driven by a strong enterprise pipeline and a flagship deployment of its new Mobile IQ SDK with Robinhood. This move underscores Stakk’s growing footprint in embedded finance security.

Spacetalk Ltd has completed a major pivot from hardware to a scalable software-as-a-service model, driving a 26% increase in active mobile subscribers and a 9% rise in annual recurring revenue to $12 million.

Beam Communications reports a robust $4 million cash position boosted by a recent $9 million divestment of Zoleo Inc., while legacy operations maintain positive cash flow amid revenue shifts.

dorsaVi reports strong US commercial growth with over 100 new physical therapy sites and a 50% rise in cash receipts, alongside a strategic leadership change and breakthrough neuromorphic technology acquisition.

PainChek has secured FDA-regulated medical device status, enabling US Remote Therapeutic Monitoring reimbursement and opening a major US growth avenue. The company targets musculoskeletal pain management in non-verbal dementia patients, a largely underserved market.

OpenLearning Limited reported a robust Q4 FY25 with SaaS annual recurring revenue growing 30% year-on-year to $3.035 million, underpinned by $3.6 million in new contracts across key Asia-Pacific markets. The company’s AI-powered learning management system continues to gain traction internationally as it targets cash flow breakeven by early 2027.

De.mem Limited has reported its strongest December quarter yet, with record cash receipts and a positive operating cash flow for the full year, underpinned by recurring revenues and strategic expansion into the gold mining sector.

Change Financial Limited has reported a record revenue quarter driven by its Vertexon platform growth and new client wins, prompting an upgrade to its FY26 financial guidance.

ImpediMed reported a solid Q2 FY26 with $3.9 million in revenue and significant reimbursement gains for its lymphoedema technology, while launching new US Heart Health and Wellness initiatives.

icetana Limited reported steady growth in Q2 FY26 with a 36% increase in annual recurring revenue and expanded partnerships across APAC and the Middle East. The company’s cash flow improved, while product enhancements aim to strengthen its AI security offerings.

Blackpearl Group has reported a record-breaking Q3 FY26 with Annual Recurring Revenue soaring 114% year-on-year to $23.7 million, driven by strong organic growth across its multi-venture platform and the emergence of Data as a Service.